• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1蛋白酶的受限分子动力学模拟:药物设计新靶点验证的第一步。

Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.

作者信息

Perryman Alexander L, Lin Jung-Hsin, McCammon J Andrew

机构信息

Howard Hughes Medical Institute, Center for Theoretical Biological Physics, and Department of Pharmacology, University of California at San Diego, La Jolla, 92093-0365, USA.

出版信息

Biopolymers. 2006 Jun 15;82(3):272-84. doi: 10.1002/bip.20497.

DOI:10.1002/bip.20497
PMID:16508951
Abstract

To test the anticorrelated relationship that was recently displayed in conventional molecular dynamics (MD) simulations, several different restrained MD simulations on a wild type and on the V82F/I84V drug-resistant mutant of HIV-1 protease were performed. This anticorrelated relationship refers to the observation that compression of the peripheral ear-to-cheek region of HIV protease (i.e., the elbow of the flap to the fulcrum and the cantilever) occurred as the active site flaps were opening, and, conversely, expansion of that ear-to-cheek region occurred as both flaps were closing. An additional examination of this anticorrelated relationship was necessary to determine whether it can be harnessed in a useful manner. Consequently, six different MD experiments were performed that incorporated pairwise distance restraints in that ear-to-cheek region (i.e., the distance between the alpha-carbons of Gly40 and Gln61 was restrained to either 7.7 or 10.5 A, in both monomers). Pushing the backbones of the ear and the cheek regions away from each other slightly did force the flaps that guard the active site to remain closed in both the wild type and the mutant systems-even though there were no ligands in the active sites. Thus, these restrained MD simulations provided evidence that the anticorrelated relationship can be exploited to affect the dynamic behavior of the flaps that guard the active site of HIV-1 protease. These simulations supported our hypothesis of the mechanism governing flap motion, and they are the first step towards validating that peripheral surface as a new target for drug design.

摘要

为了测试最近在传统分子动力学(MD)模拟中显示的反相关关系,我们对野生型和HIV-1蛋白酶的V82F/I84V耐药突变体进行了几种不同的受限MD模拟。这种反相关关系指的是观察到,在活性位点的瓣片打开时,HIV蛋白酶外周耳到颊区域(即瓣片的肘部到支点和悬臂)发生压缩,相反,当两个瓣片关闭时,该耳到颊区域发生扩张。对这种反相关关系进行额外研究,以确定是否可以以有用的方式利用它。因此,我们进行了六个不同的MD实验,在该耳到颊区域纳入了成对距离限制(即,在两个单体中,Gly40和Gln61的α-碳原子之间的距离被限制为7.7或10.5 Å)。将耳和颊区域的主链彼此稍微推开,确实迫使保护活性位点的瓣片在野生型和突变体系统中都保持关闭——即使活性位点中没有配体。因此,这些受限MD模拟提供了证据,表明可以利用反相关关系来影响保护HIV-1蛋白酶活性位点的瓣片的动态行为。这些模拟支持了我们关于瓣片运动机制的假设,并且它们是朝着将外周表面验证为药物设计新靶点迈出的第一步。

相似文献

1
Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.HIV-1蛋白酶的受限分子动力学模拟:药物设计新靶点验证的第一步。
Biopolymers. 2006 Jun 15;82(3):272-84. doi: 10.1002/bip.20497.
2
Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design.针对HIV-1蛋白酶V82F/I84V耐药突变体的一系列潜在活性位点抑制剂的优化与计算评估:基于结构的药物设计中松弛复合物方法的应用
Chem Biol Drug Des. 2006 May;67(5):336-45. doi: 10.1111/j.1747-0285.2006.00382.x.
3
HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.野生型和V82F/I84V突变体的HIV-1蛋白酶分子动力学:对耐药性的可能贡献及潜在的药物新靶点
Protein Sci. 2004 Apr;13(4):1108-23. doi: 10.1110/ps.03468904.
4
Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance.野生型和双突变型HIV-1蛋白酶与安普那韦及两种安普那韦相关抑制剂复合的分子动力学和自由能研究:结合及耐药机制
J Med Chem. 2007 Mar 22;50(6):1177-88. doi: 10.1021/jm0609162. Epub 2007 Feb 15.
5
A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.一项比较野生型与多重耐药性HIV蛋白酶的分子动力学研究:瓣片和天冬氨酸25腔尺寸的差异。
Proteins. 2007 Nov 15;69(3):551-65. doi: 10.1002/prot.21535.
6
Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.新型富勒烯类似物作为潜在HIV-1蛋白酶抑制剂的计算设计:使用三维定量构效关系、分子对接和分子动力学模拟分析富勒烯抑制剂与HIV-1蛋白酶残基之间的结合相互作用。
Bioorg Med Chem. 2008 Dec 1;16(23):9957-74. doi: 10.1016/j.bmc.2008.10.039. Epub 2008 Oct 22.
7
Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.对一种来自HIV-1蛋白酶活性位点的突变辅助侧向药物逃逸机制的见解。
Biochemistry. 2007 Dec 25;46(51):14865-77. doi: 10.1021/bi700864p. Epub 2007 Dec 4.
8
Flap opening mechanism of HIV-1 protease.HIV-1蛋白酶的瓣打开机制。
J Mol Graph Model. 2006 May;24(6):465-74. doi: 10.1016/j.jmgm.2005.08.008. Epub 2005 Sep 26.
9
Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.配体与HIV-1蛋白酶的结合途径:粗粒度和原子尺度模拟
Chem Biol Drug Des. 2007 Jan;69(1):5-13. doi: 10.1111/j.1747-0285.2007.00464.x.
10
Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.逆转录病毒蛋白酶的结构域灵活性:对耐药性突变的结构影响
Biochemistry. 1998 Feb 24;37(8):2607-21. doi: 10.1021/bi9716074.

引用本文的文献

1
An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches.利用计算机辅助药物设计方法开发小分子激酶抑制剂的最新综述
Int J Mol Sci. 2023 Sep 11;24(18):13953. doi: 10.3390/ijms241813953.
2
HIV Protease Hinge Region Insertions at Codon 38 Affect Enzyme Kinetics, Conformational Stability and Dynamics.HIV 蛋白酶铰链区 38 位密码子的插入影响酶动力学、构象稳定性和动力学。
Protein J. 2023 Oct;42(5):490-501. doi: 10.1007/s10930-023-10132-6. Epub 2023 Jul 8.
3
The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation.
利用分子动力学模拟研究高度变异的HIV-1蛋白酶对达芦那韦耐药性的结构、动力学和热力学基础。
Front Mol Biosci. 2022 Aug 15;9:927373. doi: 10.3389/fmolb.2022.927373. eCollection 2022.
4
Inhibition of the activity of HIV-1 protease through antibody binding and mutations probed by molecular dynamics simulations.通过分子动力学模拟研究抗体结合和突变对 HIV-1 蛋白酶活性的抑制作用。
Sci Rep. 2020 Mar 26;10(1):5501. doi: 10.1038/s41598-020-62423-y.
5
Effect of polarization on HIV-1protease and fluoro-substituted inhibitors binding energies by large scale molecular dynamics simulations.通过大规模分子动力学模拟研究极化对 HIV-1 蛋白酶和氟取代抑制剂结合能的影响。
Sci Rep. 2017 Feb 3;7:42223. doi: 10.1038/srep42223.
6
Identifying binding hot spots on protein surfaces by mixed-solvent molecular dynamics: HIV-1 protease as a test case.通过混合溶剂分子动力学识别蛋白质表面的结合热点:以HIV-1蛋白酶为例
Biopolymers. 2016 Jan;105(1):21-34. doi: 10.1002/bip.22742.
7
Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir.耐药性突变对HIV-1蛋白酶动力学特性的影响以及安普那韦和达芦那韦的抑制作用。
Sci Rep. 2015 May 27;5:10517. doi: 10.1038/srep10517.
8
Distinguishing binders from false positives by free energy calculations: fragment screening against the flap site of HIV protease.通过自由能计算区分结合剂与假阳性:针对HIV蛋白酶侧翼位点的片段筛选。
J Phys Chem B. 2015 Jan 22;119(3):976-88. doi: 10.1021/jp506376z. Epub 2014 Sep 17.
9
An allosteric modulator of HIV-1 protease shows equipotent inhibition of wild-type and drug-resistant proteases.一种HIV-1蛋白酶的变构调节剂对野生型和耐药蛋白酶具有同等效力的抑制作用。
J Med Chem. 2014 Aug 14;57(15):6468-78. doi: 10.1021/jm5008352. Epub 2014 Aug 1.
10
New insights into the in silico prediction of HIV protease resistance to nelfinavir.深入了解 HIV 蛋白酶对奈非那韦耐药性的计算机预测。
PLoS One. 2014 Jan 31;9(1):e87520. doi: 10.1371/journal.pone.0087520. eCollection 2014.